Carlyle Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5M | Hold |
3,496,808
| – | – | 0.67% | 3 |
|
|
2025
Q1 | $21.9M | Hold |
3,496,808
| – | – | 0.58% | 4 |
|
|
2024
Q4 | $28.4M | Hold |
3,496,808
| – | – | 0.68% | 5 |
|
|
2024
Q3 | $63.2M | Hold |
3,496,808
| – | – | 6.62% | 4 |
|
|
2024
Q2 | $35.8M | Hold |
3,496,808
| – | – | 3.4% | 5 |
|
|
2024
Q1 | $37.1M | Hold |
3,496,808
| – | – | 2.34% | 7 |
|
|
2023
Q4 | $31.9M | Hold |
3,496,808
| – | – | 1.54% | 8 |
|
|
2023
Q3 | $36.2M | Hold |
3,496,808
| – | – | 1.57% | 9 |
|
|
2023
Q2 | $50.1M | Buy |
3,496,808
+561,702
| +19% | +$8.04M | 1.78% | 6 |
|
|
2023
Q1 | $20.9M | Buy |
+2,935,106
| New | +$20.9M | 0.62% | 11 |
|